国产利福昔明与环丙沙星治疗细菌性肠道感染的成本-效果分析.pdfVIP

·药物经济学· 闺产利福昔明与坏南沙皇。台疗细菌性场道感染 的成本-效果分析 阮 蟆骨，方宝霞，李 鹏，陈富超(脚阳医学院附属东风总医院药学部，十堪市 442ω8) 中图分类号 R978.1 文献标 tR 码 B 文章编号 1672 - 2124(2侃J9 )09 -侃89 -02 摘 要 目的:评价国产利福昔明与环丙沙星治疗细菌性肠道感染的成本-效果。方法:采用循证医学方法收集国产利福昔明与 环丙沙皇治疗细菌性肠道感染的恪床资料，应用药物经济学的最小成本分析法及成本-效果分析法进行分析。结果:国产和j 福昔 明与环丙沙皇治疗细菌性肠道感染有效率分别为 97 .14% (7461768) 、 97.19% (7611783) (P 0.05); 成本-效果比分别为 151 与 9.25 句结论:环丙沙皇治疗细菌性肠遥感染灵经济。 关键词 循证医学;利福昔明;坏丙沙皇;细菌性肠遥感染;成本-效果分析 C恼t - etTectiveo回s Analysis 00 Rifaxinún VS. Ciprofloxacio in the TreatJnent of Bacterial Intestinal Infection RUAN Pin 畴， FANG Bao-xia, LI Peng, CHEN Fu-chao (Dept. of Pharmacy , The Affiliated Dongfeng General Hospital , Yunyang Medical College , Shiyan 442ω8 ， China) ABSTRACI OBJECTIVE: To evaluate the cost - effectiveness of rifaximin vs. ciprofloxacin in the treatment of bacterial intestinal infection. METHODS:ηle clinical data of rifaximin and ciprofloxacin in the treatment of bacterial intestinal infection were collected by evidence - based medicine method , which were analyzed using cost - minimization analysis and cost - effecti ven回 s analysis in pharmacoeconomics. RESULTS: The effective rates of rifaximin and ciprof1oxacin in the treatment of bacterial intestinal infection were 97.14% (7461768)and 97.19% (7611783) (P 0.05) .陀 spectively. and the cost - effectiveness ratios were 151 and 9.25. res !M比 tively. CONCLUSION: Ciprof1oxacin is more economical than rifax.imin in the treatment of bacterial intestinal infection. KEY WORDS